Does CATEQUENTINIB Cause Malignant neoplasm progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with CATEQUENTINIB. This represents 3.7% of all adverse event reports for CATEQUENTINIB.
12
Reports of Malignant neoplasm progression with CATEQUENTINIB
3.7%
of all CATEQUENTINIB reports
4
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CATEQUENTINIB?
Of the 12 reports, 4 (33.3%) resulted in death, 2 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CATEQUENTINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does CATEQUENTINIB Cause?
Myelosuppression (84)
Off label use (37)
Diarrhoea (33)
Hypertension (26)
Nausea (26)
Vomiting (26)
Rash (25)
Thrombocytopenia (24)
Fatigue (23)
Anaemia (22)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CATEQUENTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
CATEQUENTINIB vs CC-4047
CATEQUENTINIB vs CEDAZURIDINE\DECITABINE
CATEQUENTINIB vs CEDIRANIB
CATEQUENTINIB vs CEFACLOR
CATEQUENTINIB vs CEFADROXIL